<span item_type="fundamental" item_id="5b93367e63c81b4a546f461171a42e7c" counter_id="ST/US/SRTA" env="prod"></span><span item_type="announcement" item_id="581283199781311105" env="prod"></span><p>Revenue: As of FY2025 Q3, the actual value is USD 49.3 M, beating the estimate of USD 43.75 M.</p><p>EPS: As of FY2025 Q3, the actual value is USD -0.12.</p><p>EBIT: As of FY2025 Q3, the actual value is USD -6.749 M.</p><p></p><h3>Financial Metrics by Segment</h3><h4>Revenue</h4><ul><li><strong>Three Months Ended September 30, 2025</strong>: $49.3 million</li><li><strong>Nine Months Ended September 30, 2025</strong>: $130.4 million</li></ul><h4>Cost of Revenue</h4><ul><li><strong>Three Months Ended September 30, 2025</strong>: $37.7 million</li><li><strong>Nine Months Ended September 30, 2025</strong>: $100.9 million</li></ul><h4>Software Development</h4><ul><li><strong>Three Months Ended September 30, 2025</strong>: $0.5 million</li><li><strong>Nine Months Ended September 30, 2025</strong>: $1.4 million</li></ul><h4>General and Administrative</h4><ul><li><strong>Three Months Ended September 30, 2025</strong>: $16.3 million</li><li><strong>Nine Months Ended September 30, 2025</strong>: $43.0 million</li></ul><h4>Selling and Marketing</h4><ul><li><strong>Three Months Ended September 30, 2025</strong>: $0.5 million</li><li><strong>Nine Months Ended September 30, 2025</strong>: $1.1 million</li></ul><h4>Other Non-Operating Income (Loss)</h4><ul><li><strong>Three Months Ended September 30, 2025</strong>: - $4.0 million</li><li><strong>Nine Months Ended September 30, 2025</strong>: $1.3 million</li></ul><h4>Net Income (Loss) from Discontinued Operations</h4><ul><li><strong>Three Months Ended September 30, 2025</strong>: $67.1 million</li><li><strong>Nine Months Ended September 30, 2025</strong>: $64.9 million</li></ul><h3>Future Outlook and Strategy</h3><h4>Core Business Focus</h4><ul><li><strong>Revenue Growth</strong>: The company aims to continue growing its revenue through increased flight hours, ground transportation, and other services, as well as the inclusion of Keystone’s contributions.</li><li><strong>Cost Management</strong>: Efforts to improve operational leverage in ground services and higher utilization of owned fleet are expected to continue driving cost efficiencies.</li><li><strong>Integration of Keystone</strong>: The acquisition of Keystone is expected to enhance the company’s service offerings and contribute to revenue growth.</li></ul><h4>Non-Core Business</h4><ul><li><strong>Divestiture of Passenger Business</strong>: The sale of the Passenger business to Joby Aero, Inc. is expected to streamline operations and focus on the core medical services.</li><li><strong>Contingent Consideration</strong>: The company may receive up to an additional $35.0 million in contingent consideration from the sale of the Passenger business, subject to certain performance targets.</li></ul><h4>Priority</h4><ul><li><strong>Operational Efficiency</strong>: Continued focus on improving flight margins and gross margins through better utilization of assets and cost management.</li><li><strong>Market Expansion</strong>: Strategic plans to expand into new markets and attract new clients to drive revenue growth.</li></ul><h3>Cash Flow</h3><ul><li><strong>Net Cash Used in Operating Activities</strong>: - $40.6 million for the nine months ended September 30, 2025.</li><li><strong>Net Cash Provided by Investing Activities</strong>: $51.5 million for the nine months ended September 30, 2025.</li><li><strong>Net Cash Used in Financing Activities</strong>: - $7.2 million for the nine months ended September 30, 2025.</li></ul><h3>Unique Metrics</h3><ul><li><strong>Adjusted EBITDA</strong>: $4.2 million for the three months ended September 30, 2025, and $7.1 million for the nine months ended September 30, 2025.</li><li><strong>Gross Profit</strong>: $9.5 million for the three months ended September 30, 2025, and $23.2 million for the nine months ended September 30, 2025.</li><li><strong>Flight Profit</strong>: $11.6 million for the three months ended September 30, 2025, and $29.5 million for the nine months ended September 30, 2025.</li><li><strong>Gross Margin</strong>: 19.4% for the three months ended September 30, 2025, and 17.8% for the nine months ended September 30, 2025.</li><li><strong>Flight Margin</strong>: 23.6% for the three months ended September 30, 2025, and 22.6% for the nine months ended September 30, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1779128/000162828025050870/blde-20250930.htm"></span></li></ul>

Strata Critical Medical | 10-Q: FY2025 Q3 Revenue Beats Estimate at USD 49.3 M